CDMO in Poland for sale

Successful pharma CDMO in Poland for sale

• Sales: more than 10 million EUR
• EBITDA: approx. 2 million EUR
• Location: Poland
• Reason for sale: The owners wants to find investor/acquirer, who is able to perform a financial injection to stabilize the company’s situation (investment into working capital)
• #CFIE PHS053

Overview of this pharma CDMO in Poland for sale

This company for sale is a contract manufacturer and development company with an excellent market position and growth outlook. The company management has partnered with an advisor in order to find a suitable investor. The owner is ready to discuss offers for a significant % of the shares, he is also open to a 100% share sale. However, injection into working capital is required, as this is vital to the company.

Profile of this CDMO company in Europe

This company for sale is a successful contract development and manufacturer in the pharma industry. The company provides contract manufacturing (CDMO) and R&D services of pharmaceuticals and dietary supplements for leading pharmaceutical companies in the region of central Europe. The company for sale has signed a contract with market leaders and top companies in the pharma manufacturing industry.

The company has a very strong market position in the region. Its quality is confirmed by certificates GMP/HACCP and many others. The company owns a modern machine park and R&D facilities.

The management of the company is looking for an investor, or a strategic partner, as the company needs equity for working capital (to boost sales), debt refinancing and further investments.

Subscribe for similar companies for sale
Subscribe now and we will inform you when similar companies for sale come up!

Products and services of this pharma contract manufacturer for sale

The company provides its clients with an option of a complex service, including the development and manufacturing of pharma products. Its specialization is CDMO of OTC/Rx & diet supplements.

The company specializes in the contract production of OTX / Rx drugs and dietary supplements for the largest pharmaceutical companies. The company has an extensive R&D centre and implemented grants for its further development, where it generates about 10% of revenues.

The company has a very positive outlook. New contracts for the upcoming years are valued in tens of millions EUR.  At the same time, it has free space to scale business. The company currently implements grants from the European Union which support the development of drugs. The company wants to strengthen its position in contract production in the CEE region. The company wants also to establish its position in the contract product development business.

The company has a stable situation regarding revenues – its revenue is diversified to a large extent. The company is very flexible and able in the production of small series or large batches, all according to customers preferences.

Highlights of this CDMO for sale

• The company can produce a small series of difficult products, which is a huge competitive advantage.
• The company has a long history and a valuable know-how
• The company has a 5%-10% EBITDA margin

More information on this cDMO in Poland for sale

Please get in touch if you are interested in learning more about this cDMO in Poland for sale. For more cmo companies for sale please visit the section cmo companies for sale. For other cmo buyers, please visit the section cmo companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.